TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
出版年份 2018 全文链接
标题
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-11-13
DOI
10.1038/s41467-018-06699-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structure and regulation of the human INO80–nucleosome complex
- (2018) Rafael Ayala et al. NATURE
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- MYCN induces neuroblastoma in primary neural crest cells
- (2017) R R Olsen et al. ONCOGENE
- Models of human core transcriptional regulatory circuitries
- (2016) Violaine Saint-André et al. GENOME RESEARCH
- Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
- (2016) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- FourCSeq: analysis of 4C sequencing data
- (2015) Felix A. Klein et al. BIOINFORMATICS
- MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
- (2015) Anneleen Beckers et al. CANCER LETTERS
- Microphthalmia-associated transcription factor/T-box factor-2 axis acts through Cyclin D1 to regulate melanocyte proliferation
- (2015) L. Pan et al. CELL PROLIFERATION
- Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition
- (2015) A. Henssen et al. CLINICAL CANCER RESEARCH
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Chromatin architecture reorganization during stem cell differentiation
- (2015) Jesse R. Dixon et al. NATURE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes
- (2015) Kumarasamypet M Mohankumar et al. NATURE GENETICS
- The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
- (2015) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
- (2015) Ying Su et al. Cell Reports
- T-box transcription factors in cancer biology
- (2014) Sabina Wansleben et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression
- (2014) G Denecker et al. CELL DEATH AND DIFFERENTIATION
- TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells
- (2014) Bo Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Emergence of New ALK Mutations at Relapse of Neuroblastoma
- (2014) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
- (2014) K Althoff et al. ONCOGENE
- ViVar: A Comprehensive Platform for the Analysis and Visualization of Structural Genomic Variation
- (2014) Tom Sante et al. PLoS One
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
- (2013) Candy Kumps et al. PLoS One
- REST: an oncogene or a tumor suppressor?
- (2013) Sara Negrini et al. TRENDS IN CELL BIOLOGY
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Robust 4C-seq data analysis to screen for regulatory DNA interactions
- (2012) Harmen J G van de Werken et al. NATURE METHODS
- i-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules
- (2012) Carl Herrmann et al. NUCLEIC ACIDS RESEARCH
- The T Box Transcription Factor TBX2 Promotes Epithelial-Mesenchymal Transition and Invasion of Normal and Malignant Breast Epithelial Cells
- (2012) Bin Wang et al. PLoS One
- Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
- (2011) Valentina Boeva et al. BIOINFORMATICS
- Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
- (2010) Daniel Muth et al. CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death
- (2010) Giovanni Passiatore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
- (2009) Isabella Eckerle et al. CANCER LETTERS
- Cholinergic switch associated with morphological differentiation in neuroblastoma
- (2009) Franck Bourdeaut et al. JOURNAL OF PATHOLOGY
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started